BICYCLE THERAPEUTICS PLC
CAMBRIDGE, X0 · CIK 0001761612 · Biotech · Public
Bicyclic peptide therapeutics for solid tumors
bicycletherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $555M
- 1 Form D · Jun 2024
- 28 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $555,499,983 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2303 | Relay Therapeutics | — | $30M |
| 2304 | Acurx Pharmaceuticals, Inc. | — | $17M |
| 2305 | Congruence Therapeutics | — | — |
| 2306 | BICYCLE THERAPEUTICS PLC | — | $555M |
| 2307 | Gatehouse Bio, Inc. | — | $5.4M |
| 2308 | Synlico Inc. | — | $5.2M |
| 2309 | Humonix Biosciences Inc | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- SANTIAGO ARROYOExecutive Officer
- FELIX BAKERDirector
- JANICE BOURQUEDirector
- NIGEL CROCKETTExecutive Officer
- JOSE-CARLOS GUTIERREZ-RAMOSDirector
- MICHAEL HANNAYExecutive Officer
- NICHOLAS KEENExecutive Officer
- RICHARD KENDERDirector
- KEVIN LEEDirector · Executive Officer
- PIERRE LEGAULTDirector
- ALISTAIR MILNESExecutive Officer
- STEPHEN SANDSDirector
- MICHAEL SKYNNERExecutive Officer
- GREGORY WINTERDirector
- ALETHIA YOUNGExecutive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.